Table 1. Patient demographics.
Patient | Gender | Age (years) | INTERMACS | Type of device | LVEF (%) | Cardiomyopathy | Follow-up (days) | Status |
---|---|---|---|---|---|---|---|---|
1 | Female | 60 | III | HA5 | 20 | Non-ischemic | 429 | Alive, cardiac transplant |
2 | Male | 55 | III | HA5 | 11 | Ischemic | 393 | Deceased (intracranial bleeding) |
3 | Male | 58 | III | HA5 | 15 | Ischemic | 458 | Alive on LVAD |
4 | Male | 70 | III | HA5 | 20 | Non-ischemic | 325 | Alive on LVAD |
5 | Male | 62 | II | HA5 | 20 | Non-ischemic | 217 | LVAD exchange (pump thrombosis) |
6 | Male | 61 | III | HA5 | 15 | Ischemic | 233 | Alive on LVAD |
7 | Female | 61 | III | aVAD | 30 | Non-ischemic | 121 | Alive on LVAD |
8 | Male | 54 | III | aVAD | 15 | Non-ischemic | 108 | Alive on LVAD |
9 | Male | 49 | III | aVAD | 25 | Non-ischemic | 73 | Alive on LVAD |
10 | Male | 62 | III | aVAD | 15 | Ischemic | 52 | Alive on LVAD |
11 | Male | 57 | III | aVAD | 16 | Non-ischemic | 29 | Alive on LVAD |
Age, INTERMACS and LVEF are given at time of LVAD implantation. INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support Score; HA5, Heart Assist 5; LVEF, left ventricular ejection fraction.